As of 2025-11-14, the Relative Valuation of Inhibrx Inc (INBX) is 688.22 USD. This relative valuation is based on P/E multiples. With the latest stock price at 74.62 USD, the upside of Inhibrx Inc based on Relative Valuation is 822.3%.
The range of the Relative Valuation is (136.42) - 1,554.32 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 17.4x | 16.9x |
| Forward P/E multiples | 16.6x - 17.4x | 17.0x |
| Fair Price | (136.42) - 1,554.32 | 688.22 |
| Upside | -282.8% - 1983.0% | 822.3% |
| Date | P/E |
| 2025-11-13 | -9.09 |
| 2025-11-12 | -8.83 |
| 2025-11-11 | -9.37 |
| 2025-11-10 | -9.51 |
| 2025-11-07 | -9.71 |
| 2025-11-06 | -9.75 |
| 2025-11-05 | -9.90 |
| 2025-11-04 | -9.87 |
| 2025-11-03 | -9.80 |
| 2025-10-31 | -9.83 |
| 2025-10-30 | -9.45 |
| 2025-10-29 | -9.27 |
| 2025-10-28 | -8.24 |
| 2025-10-27 | -7.08 |
| 2025-10-24 | -6.90 |
| 2025-10-23 | -3.41 |
| 2025-10-22 | -3.79 |
| 2025-10-21 | -4.52 |
| 2025-10-20 | -4.60 |
| 2025-10-17 | -4.48 |
| 2025-10-16 | -4.40 |
| 2025-10-15 | -4.33 |
| 2025-10-14 | -4.19 |
| 2025-10-13 | -4.14 |
| 2025-10-10 | -3.91 |
| 2025-10-09 | -4.21 |
| 2025-10-08 | -4.05 |
| 2025-10-07 | -4.03 |
| 2025-10-06 | -4.21 |
| 2025-10-03 | -4.29 |
| 2025-10-02 | -4.22 |
| 2025-10-01 | -4.09 |
| 2025-09-30 | -4.05 |
| 2025-09-29 | -3.89 |
| 2025-09-26 | -3.93 |
| 2025-09-25 | -3.83 |
| 2025-09-24 | -3.57 |
| 2025-09-23 | -3.48 |
| 2025-09-22 | -3.26 |
| 2025-09-19 | -3.32 |
| 2025-09-18 | -3.21 |
| 2025-09-17 | -3.19 |
| 2025-09-16 | -3.20 |
| 2025-09-15 | -3.27 |
| 2025-09-12 | -3.31 |
| 2025-09-11 | -3.42 |
| 2025-09-10 | -3.33 |
| 2025-09-09 | -3.56 |
| 2025-09-08 | -3.50 |
| 2025-09-05 | -3.39 |